177
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Understanding Regional Patterns of Overdose Deaths Related to Opioids and Psychostimulants

ORCID Icon, , ORCID Icon, , , , , ORCID Icon, & show all

References

  • Beletsky, L., Davis, C. S., Anderson, E., & Burris, S. (2008). The law (and politics) of safe injection facilities in the United States. American Journal of Public Health, 98(2), 231–237. https://doi.org/10.2105/AJPH.2006.103747
  • Brooklyn, J. R., & Sigmon, S. C. (2017). Vermont hub-and-spoke model of care for opioid use disorder: development, implementation, and impact. Journal of Addiction Medicine, 11(4), 286–292. https://doi.org/10.1097/ADM.0000000000000310
  • Cano, M., & Huang, Y. (2021). Overdose deaths involving psychostimulants with abuse potential, excluding cocaine: State-level differences and the role of opioids. Drug and Alcohol Dependence, 218, 108384. https://doi.org/10.1016/j.drugalcdep.2020.108384
  • Centers for Disease Control and Prevention. (2021). CDC/ATSDR SVI data and documentation download. https://www.atsdr.cdc.gov/placeandhealth/svi/data_documentation_download.html
  • Chan, B., Freeman, M., Kondo, K., Ayers, C., Montgomery, J., Paynter, R., & Kansagara, D. (2019). Pharmacotherapy for methamphetamine/amphetamine use disorder-a systematic review and meta-analysis. Addiction (Abingdon, England), 114(12), 2122–2136. https://doi.org/10.1111/add.14755
  • Clark, A. K., Wilder, C. M., & Winstanley, E. L. (2014). A systematic review of community opioid overdose prevention and naloxone distribution programs. Journal of Addiction Medicine, 8(3), 153–163. https://doi.org/10.1097/ADM.0000000000000034
  • Commonwealth of Pennsylvania. (2017). Governor Wolf Announces $5 Million Funding for Naloxone to First Responders.
  • Compton, W. M., Valentino, R. J., & DuPont, R. L. (2021). Polysubstance use in the U.S. opioid crisis. Molecular Psychiatry, 26(1), 41–50. https://doi.org/10.1038/s41380-020-00949-3
  • Dasgupta, N., Beletsky, L., & Ciccarone, D. (2017). Opioid crisis: No easy fix to its social and economic determinants. American Journal of Public Health, 108(2), 182–186. https://doi.org/10.2105/AJPH.2017.304187
  • Ellis, M. S., Kasper, Z. A., & Cicero, T. J. (2018). Twin epidemics: The surging rise of methamphetamine use in chronic opioid users. Drug and Alcohol Dependence, 193, 14–20. https://doi.org/10.1016/j.drugalcdep.2018.08.029
  • Erfanian, E., Collins, A. R., & Grossmam, D. (2018). The impact of naloxone access laws on opioid overdose deaths in the U.S (Working Paper 2018-03). https://ideas.repec.org/p/rri/wpaper/2018wp03.html
  • Flanagan, B. E., Hallisey, E. J., Adams, E., & Lavery, A. (2018). Measuring community vulnerability to natural and anthropogenic hazards: The centers for disease control and prevention’s social vulnerability index. Journal of Environmental Health, 80(10), 34–36.
  • Frankenfeld, C. L., & Leslie, T. F. (2019). County-level socioeconomic factors and residential racial, Hispanic, poverty, and unemployment segregation associated with drug overdose deaths in the United States, 2013–2017. Annals of Epidemiology, 35, 12–19. https://doi.org/10.1016/j.annepidem.2019.04.009
  • Haffajee, R. L., Lin, L. A., Bohnert, A. S. B., & Goldstick, J. E. (2019). Characteristics of US counties with high opioid overdose mortality and low capacity to deliver medications for opioid use disorder. JAMA Network Open, 2(6), e196373-e196373. https://doi.org/10.1001/jamanetworkopen.2019.6373
  • Haley, D. F., & Saitz, R. (2020). The opioid epidemic during the COVID-19 pandemic. JAMA, 324(16), 1615–1617. https://doi.org/10.1001/jama.2020.18543
  • Hall, O. T., Hall, O. E., Rood, K. M., McKiever, M. E., Teater, J., & Senay, A. (2020). Pregnancy-associated mortality due to accidental drug overdose and suicide in Ohio, 2009–2018. Obstetrics & Gynecology, 136(4), 654–656. https://doi.org/10.1097/AOG.0000000000004066
  • Harris, R. E., Richardson, J., Frasso, R., & Anderson, E. D. (2018). Perceptions about supervised injection facilities among people who inject drugs in Philadelphia. International Journal of Drug Policy, 52, 56–61. https://doi.org/10.1016/j.drugpo.2017.11.005
  • Hedegaard, H., Miniño, A. M., & Warner, M. (2021). Co-involvement of opioids in drug overdose deaths involving cocaine and psychostimulants. NCHS Data Brief, (406), 1–8. https://pubmed.ncbi.nlm.nih.gov/33814035/
  • Heinzerling, K. G., Swanson, A.-N., Hall, T. M., Yi, Y., Wu, Y., & Shoptaw, S. J. (2014). Randomized, placebo-controlled trial of bupropion in methamphetamine-dependent participants with less than daily methamphetamine use. Addiction (Abingdon, England), 109(11), 1878–1886. https://doi.org/10.1111/add.12636
  • Hollingsworth, A., Ruhm, C. J., & Simon, K. (2017). Macroeconomic conditions and opioid abuse. Journal of Health Economics, 56, 222–233. https://doi.org/10.1016/j.jhealeco.2017.07.009
  • Huber, C. (2020). How to create choropleth maps using the COVID-19 data from Johns Hopkins University. https://blog.stata.com/2020/04/07/how-to-create-choropleth-maps-using-the-covid-19-data-from-johns-hopkins-university/
  • Jalal, H., Buchanich, J. M., Roberts, M. S., Balmert, L. C., Zhang, K., & Burke, D. S. (2018). Changing dynamics of the drug overdose epidemic in the United States from 1979 through 2016. Science, 361(6408), eaau1184. https://doi.org/10.1126/science.aau1184
  • Kariisa, M., Seth, P., Scholl, L., Wilson, N., & Davis, N. L. (2021). Drug overdose deaths involving cocaine and psychostimulants with abuse potential among racial and ethnic groups – United States, 2004–2019. Drug and Alcohol Dependence, 227, 109001. https://doi.org/10.1016/j.drugalcdep.2021.109001
  • Kazerouni, N. J., Irwin, A. N., Levander, X. A., Geddes, J., Johnston, K., Gostanian, C. J., Mayfield, B. S., Montgomery, B. T., Graalum, D. C., & Hartung, D. M. (2021). Pharmacy-related buprenorphine access barriers: An audit of pharmacies in counties with a high opioid overdose burden. Drug and Alcohol Dependence, 224, 108729. https://doi.org/10.1016/j.drugalcdep.2021.108729
  • Khatri, U. G., Viner, K., & Perrone, J. (2018). Lethal fentanyl and cocaine intoxication. New England Journal of Medicine, 379(18), 1782–1782. https://doi.org/10.1056/NEJMc1809521
  • Krieger, M. S., Goedel, W. C., Buxton, J. A., Lysyshyn, M., Bernstein, E., Sherman, S. G., Rich, J. D., Hadland, S. E., Green, T. C., & Marshall, B. D. (2018). Use of rapid fentanyl test strips among young adults who use drugs. International Journal of Drug Policy, 61, 52–58. https://doi.org/10.1016/j.drugpo.2018.09.009
  • Krieger, M. S., Yedinak, J. L., Buxton, J. A., Lysyshyn, M., Bernstein, E., Rich, J. D., Green, T. C., Hadland, S. E., & Marshall, B. D. L. (2018). High willingness to use rapid fentanyl test strips among young adults who use drugs. Harm Reduction Journal, 15(1), 7. https://doi.org/10.1186/s12954-018-0213-2
  • Langabeer, J. R., Chambers, K. A., Cardenas-Turanzas, M., & Champagne-Langabeer, T. (2020). County-level factors underlying opioid mortality in the United States. Substance Abuse, 43(1), 76–82. https://doi.org/10.1080/08897077.2020.1740379
  • Lehnert, E. A., Wilt, G., Flanagan, B., & Hallisey, E. (2020). Spatial exploration of the CDC’s Social Vulnerability Index and heat-related health outcomes in Georgia. International Journal of Disaster Risk Reduction, 46, 101517. https://doi.org/10.1016/j.ijdrr.2020.101517
  • Mason, M., Welch, S. B., Arunkumar, P., Post, L. A., & Feinglass, J. M. (2021). Notes from the field: Opioid overdose deaths before, during, and after an 11-week COVID-19 stay-at-home order—cook county, Illinois, January 1, 2018–October 6, 2020. Morbidity and Mortality Weekly Report, 70(10), 362–363. https://doi.org/10.15585/mmwr.mm7010a3
  • Miele, G. M., Caton, L., Freese, T. E., McGovern, M., Darfler, K., Antonini, V. P., Perez, M., & Rawson, R. (2020). Implementation of the hub and spoke model for opioid use disorders in California: Rationale, design and anticipated impact. Journal of Substance Abuse Treatment, 108, 20–25. https://doi.org/10.1016/j.jsat.2019.07.013
  • Mohlman, M. K., Tanzman, B., Finison, K., Pinette, M., & Jones, C. (2016). Impact of medication-assisted treatment for opioid addiction on medicaid expenditures and health services utilization rates in Vermont. Journal of Substance Abuse Treatment, 67, 9–14. https://doi.org/10.1016/j.jsat.2016.05.002
  • Monnat, S. M., Peters, D. J., Berg, M. T., & Hochstetler, A. (2019). Using census data to understand county-level differences in overall drug mortality and opioid-related mortality by opioid type. American Journal of Public Health, 109(8), 1084–1091. https://doi.org/10.2105/AJPH.2019.305136
  • Naqvi, A. (2021). Stata graphs: Bi-variate maps. https://medium.com/the-stata-guide/stata-graphs-bi-variate-maps-b1e96dd4c2be
  • Naqvi, A. (2023). Bimap: Stata module to produce bivariate maps. https://econpapers.repec.org/software/bocbocode/S459063.htm
  • National Center for Health Statistics. (2020). 1989-2018 Detailed Mortality – All Counties, as compiled from data provided by the 57 vital statistics jurisdictions through the Vital Statistics Cooperative Program.
  • Paulus, M. P., & Stewart, J. L. (2020). Neurobiology, clinical presentation, and treatment of methamphetamine use disorder: A review. JAMA Psychiatry, 77(9), 959–966. https://doi.org/10.1001/jamapsychiatry.2020.0246
  • Peiper, N. C., Clarke, S. D., Vincent, L. B., Ciccarone, D., Kral, A. H., & Zibbell, J. E. (2019). Fentanyl test strips as an opioid overdose prevention strategy: Findings from a syringe services program in the Southeastern United States. International Journal of Drug Policy, 63, 122–128. https://doi.org/10.1016/j.drugpo.2018.08.007
  • Pennsylvania Department of Health. (2020). Wolf administration announces latest PacMAT grant recipients to help fight the opioid addiction epidemic. https://www.media.pa.gov/Pages/Health-Details.aspx?newsid=921
  • Rawson, R. A., Rieckmann, T., Cousins, S., McCann, M., & Pearce, R. (2019). Patient perceptions of treatment with medication treatment for opioid use disorder (MOUD) in the Vermont hub-and-spoke system. Preventive Medicine, 128, 105785. https://doi.org/10.1016/j.ypmed.2019.105785
  • Reif, S., Brolin, M. F., Stewart, M. T., Fuchs, T. J., Speaker, E., & Mazel, S. B. (2020). The Washington State Hub and Spoke Model to increase access to medication treatment for opioid use disorders. Journal of Substance Abuse Treatment, 108, 33–39. https://doi.org/10.1016/j.jsat.2019.07.007
  • Ruhm, C. J. (2017). Geographic variation in opioid and heroin involved drug poisoning mortality rates. American Journal of Preventive Medicine, 53(6), 745–753. https://doi.org/10.1016/j.amepre.2017.06.009
  • Ruhm, C. J. (2018). Corrected US opioid-involved drug poisoning deaths and mortality rates, 1999–2015. Addiction (Abingdon, England), 113(7), 1339–1344. https://doi.org/10.1111/add.14144
  • Saloner, B., Whitley, P., LaRue, L., Dawson, E., & Huskey, A. (2021). Polysubstance use among patients treated with buprenorphine from a national urine drug test database. JAMA Network Open, 4(9), e2123019. https://doi.org/10.1001/jamanetworkopen.2021.23019
  • Schalkoff, C. A., Lancaster, K. E., Gaynes, B. N., Wang, V., Pence, B. W., Miller, W. C., & Go, V. F. (2020). The opioid and related drug epidemics in rural Appalachia: A systematic review of populations affected, risk factors, and infectious diseases. Substance Abuse, 41(1), 35–69. https://doi.org/10.1080/08897077.2019.1635555
  • Segel, J. E., & Winkelman, T. N. A. (2021). Persistence and Pervasiveness: Early Wave Opioid Overdose Death Rates Associated With Subsequent Overdose Death Rates. Public Health Reports, 136(2), 212–218. https://doi.org/10.1177/0033354920969171
  • Shearer, R. D., Shippee, N. D., & Winkelman, T. N. A. (2021). Characterizing trends in methamphetamine-related health care use when there is no ICD code for “methamphetamine use disorder”. Journal of Substance Abuse Treatment, 127, 108369. https://doi.org/10.1016/j.jsat.2021.108369
  • Trivedi, M. H., Walker, R., Ling, W., Dela Cruz, A., Sharma, G., Carmody, T., Ghitza, U. E., Wahle, A., Kim, M., Shores-Wilson, K., Sparenborg, S., Coffin, P., Schmitz, J., Wiest, K., Bart, G., Sonne, S. C., Wakhlu, S., Rush, A. J., Nunes, E. V., & Shoptaw, S. (2021). Bupropion and naltrexone in methamphetamine use disorder. New England Journal of Medicine, 384(2), 140–153. https://doi.org/10.1056/NEJMoa2020214
  • Twillman, R. K., Dawson, E., LaRue, L., Guevara, M. G., Whitley, P., & Huskey, A. (2020). Evaluation of trends of near-real-time urine drug test results for methamphetamine, cocaine, heroin, and fentanyl. JAMA Network Open, 3(1), e1918514-e1918514. https://doi.org/10.1001/jamanetworkopen.2019.18514
  • United States Department of Agriculture Economic Research Service. (2016). Rural-urban continuum codes. http://www.ers.usda.gov/data-products/rural-urban-continuum-codes
  • US Census Bureau. (2021a). Annual county population estimates 2010-2020. https://www2.census.gov/programs-surveys/popest/datasets/2010-2020/counties/totals/
  • US Census Bureau. (2021b). Census regions and divisions of the United States. https://www2.census.gov/geo/pdfs/maps-data/maps/reference/us_regdiv.pdf
  • Volkow, N. D., Frieden, T. R., Hyde, P. S., & Cha, S. S. (2014). Medication-assisted therapies–tackling the opioid-overdose epidemic. New England Journal of Medicine, 370(22), 2063–2066. https://doi.org/10.1056/NEJMp1402780
  • Wilson, N., Kariisa, M., Seth, P., Smith, H., & Davis, N. L. (2020). Drug and opioid-involved overdose deaths - United States, 2017-2018. Morbidity and Mortality Weekly Report, 69(11), 290–297. https://doi.org/10.15585/mmwr.mm6911a4
  • Winkelman, T. N. A., Admon, L. K., Jennings, L., Shippee, N. D., Richardson, C. R., & Bart, G. (2018). Evaluation of amphetamine-related hospitalizations and associated clinical outcomes and costs in the United States. JAMA Network Open, 1(6), e183758-e183758. https://doi.org/10.1001/jamanetworkopen.2018.3758
  • Winograd, R. P., Wood, C. A., Stringfellow, E. J., Presnall, N., Duello, A., Horn, P., & Rudder, T. (2020). Implementation and evaluation of Missouri’s Medication First treatment approach for opioid use disorder in publicly-funded substance use treatment programs. Journal of Substance Abuse Treatment, 108, 55–64. https://doi.org/10.1016/j.jsat.2019.06.015
  • Winstanley, E. L., Lander, L. R., Berry, J. H., Mahoney, J. J., III, Zheng, W., Herschler, J., Marshalek, P., Sayres, S., Mason, J., & Haut, M. W. (2020). West Virginia’s model of buprenorphine expansion: Preliminary results. Journal of Substance Abuse Treatment, 108, 40–47. https://doi.org/10.1016/j.jsat.2019.05.005
  • Wolf, T. (2019). Pennsylvania’s use of federal funding to address the opioid epidemic. https://www.congress.gov/116/meeting/house/110367/documents/HHRG-116-IF02-20200114-SD022.pdf
  • Yedinak, J. L., Li, Y., Krieger, M. S., Howe, K., Ndoye, C. D., Lee, H., Civitarese, A. M., Marak, T., Nelson, E., Samuels, E. A., Chan, P. A., Bertrand, T., & Marshall, B. D. (2021). Machine learning takes a village: Assessing neighbourhood-level vulnerability for an overdose and infectious disease outbreak. International Journal of Drug Policy, 96, 103395. https://doi.org/10.1016/j.drugpo.2021.103395

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.